Email me when Robert Dickey files a new Ownership 3,4,5 report.
⭐ Subscribe ⭐| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| RSLS | ReShape Lifesciences Inc. | Chief Financial Officer | $342 | Aug 15, 2025 | ||
| AIMI | AIM ImmunoTech Inc. | Chief Financial Officer | Apr 4, 2022 | |||
| AGGX | AngioGenex, Inc. | Director, INDEPENDENT DIRECTOR | Dec 31, 2021 | |||
| ENVB | Enveric Biosciences, Inc. | Chief Financial Officer | Sep 9, 2022 | |||
| NVTA | Invitae Corp | Interim Chief Financial Officer Exhibit List: Exhibit 24 - Power of Attorney | Aug 14, 2023 |
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|